A drug combination known as ABVD and commonly used in chemotherapy has been linked to an increased production of eggs in women, offering the prospect of a solution for low fertility. Currently, IVF treatments are extremely expensive — around $11,000 to $12,000 on average in the U.S. — so this drug could potentially offer a more affordable solution. In a small study at the University of Edinburgh, the ovary tissue of 14 women treated with the drug were compared to that of 12 healthy women. “This study involves only a few patients, but its findings were consistent and its outcome may be significant and far-reaching,” said Professor Evelyn Telfer from the School of Biological Sciences, author of the study which was published in the Human Reproduction journal on Monday. “We need to know more about how this drug combination acts on the ovaries, and the implications of this.”
Read the full story at CNBC.